stockportfolio.pro
Stocks / ADCT vs WGRX
ADCT vs WGRX
ADC Therapeutics SA and Wellgistics Health, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| ADC Therapeutics SA (ADCT) | Wellgistics Health, Inc. (WGRX) | |
|---|---|---|
| Market cap | $0.1B | $0.0B |
| Revenue (latest FY) | $81.36M | $23.34M |
| Net income (latest FY) | $-142.62M | $-101.27M |
| Revenue growth (5y CAGR) | -27.1% | -10.7% |
| Net margin | -175.3% | -433.9% |
| Return on equity | 76.7% | 813.6% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ADCT — free Open WGRX — freeFrequently asked questions
Which is bigger, ADCT or WGRX?
ADC Therapeutics SA is larger by market capitalization — $0.1B versus $0.0B.
Which grows faster, ADCT or WGRX?
Over the last five fiscal years, Wellgistics Health, Inc. grew revenue faster — -10.7%/yr versus -27.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.